advertisement

WGC-2021

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (115)

Showing records 1 to 25

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
89876 Bimatoprost Implant: First Approval
Shirley M
Drugs and Aging 2020; 37: 457-462
90570 Nanoscale Drug Delivery Systems for Glaucoma: Experimental and In Silico Advances
Sharma S
Current Topics in Medicinal Chemistry 2020; 0:
90679 Ocular co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation
Taka E
Pharmaceuticals (Basel, Switzerland) 2020; 13:
90021 Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma
Kompella UB
Progress in Retinal and Eye Research 2020; 0: 100901
90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Cesar ALA
Journal of Biomedical Materials Research - Part A 2020; 0:
90507 The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study
Guo Y
BMC Ophthalmology 2020; 20: 277
90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Han X
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355
90630 Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy
Cuggino JC
Materials science & engineering. C, Materials for biological applications 2021; 118: 111383
90502 The Efficacy Between Conventional Lid Hygiene and Additional Thermal Pulsatile System in Meibomian Gland Dysfunction Patients Treated with Long-Term Anti-Glaucoma Medications in a Randomized Controlled Trial
Kasetsuwan N
Clinical Ophthalmology 2020; 14: 2891-2902
90661 Polypeptide and glycosaminoglycan polysaccharide as stabilizing polymers in nanocrystals for a safe ocular hypotensive effect
Donia M
International Journal of Biological Macromolecules 2020; 162: 1699-1710
90627 Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma
Nguyen DD
Acta biomaterialia 2020; 111: 302-315
90459 Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: A 2-year randomized evaluation study
Mohammed I
Clinical and Experimental Ophthalmology 2020; 48: 973-982
90672 Effect of aging on heat transfer, fluid flow and drug transport in anterior human eye: A computational study
Bhandari A
Journal of Controlled Release 2020; 328: 286-303
89989 Intractable Ocular Diseases and Treatment Progress
Zhang X
AAPS PharmSciTech 2020; 21: 236
90473 Effect of Long-Term Topical Antiglaucoma Medication Use on the Ocular Surface
Awe OO
Nigerian medical journal : journal of the Nigeria Medical Association 2020; 61: 184-188
90851 Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Mietzner R
Pharmaceutics 2020; 12:
90252 Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
Gozawa M
BMC Ophthalmology 2020; 20: 244
90627 Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma
Nguyen DD
Acta biomaterialia 2020; 111: 302-315
90725 Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma
Stack T
Small (Weinheim an der Bergstrasse, Germany) 2020; 16: e2004205
90655 Numerical modeling of therapeutic lens drug delivery in the anterior human eye for the treatment of primary open-angle glaucoma
Bhandari A
Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine 2020; 234: 942-954
90541 Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties
Ismail A
International Journal of Pharmaceutics 2020; 583: 119402
89986 Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment
Kwon S
International Journal of Nanomedicine 2020; 15: 5745-5765
90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Schnichels S
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260
90630 Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy
Tártara LI
Materials science & engineering. C, Materials for biological applications 2021; 118: 111383
89989 Intractable Ocular Diseases and Treatment Progress
Li S
AAPS PharmSciTech 2020; 21: 236

Issue 21-3

Change Issue


advertisement

Oculus